Genitourinary Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Bladder Cancer and Renal Cell Carcinoma

published 3 months ago by Dr Neil Love

Featuring perspectives from Drs Sumanta K Pal and David I Quinn on the following topics: Renal Cell Carcinoma Introduction (0:00) First-line treatment of metastatic RCC (4:49) Relapsed disease (21:26) Urothelial Bladder Cancer (UBC) Immune checkpoint inhibitors (ICIs) for non-muscle-invasive UBC (24:59) (Neo)adjuvant ICIs (28:26) ICIs with or without other systemic therapies; novel strategies (35:13) New data sets further defining the role of enfortumab vedotin in UBC (38:45) Optimal integration of erdafitinib into the management of relapsed/refractory UBC (53:09) CME information and select publications

more episodes from Research To Practice | Oncology Videos